Located in Newton MA but referenced as a NorthWestern University, Evaston IL,spinout, Immunochem Therapeutics is structured around developing a new class of brain-specific anti-inflammatory drugs with a wide range of therapeutic applications and an immense commercial potential. Brain inflammation is understood to be a primary cause of neuronal/ synaptic damage and mental decline in brain trauma, Alzheimers disease, and other neurodegenerative disorders. A clinical stage start-up, the firm is addressing development of a new class of brain-specific anti-inflammatory drugs to treat and to prevent Alzheimer's disease and other conditions where brain inflammation is thought to play an important role.
